SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.58%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$300M
AUM Growth
+$300M
(-40%)
Cap. Flow
-$208M
Cap. Flow
% of AUM
-69.57%
Top 10 Holdings %
Top 10 Hldgs %
37.39%
Holding
273
New
28
Increased
50
Reduced
66
Closed
73
Top Buys
| 1 |
Alkermes
ALKS
|
$10.5M |
| 2 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$6.24M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.16M |
| 4 |
United Therapeutics
UTHR
|
$5.45M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$5.01M |
Top Sells
| 1 |
Biogen
BIIB
|
$22.9M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 3 |
Viatris
VTRS
|
$15.2M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$15M |
| 5 |
IOC
Interoil Corporation
IOC
|
$11.1M |
Sector Composition
| 1 | Healthcare | 63.58% |
| 2 | Technology | 2.74% |
| 3 | Consumer Staples | 0.59% |
| 4 | Industrials | 0.54% |
| 5 | Materials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares Russell 2000 ETF
IWM
$67B
| $33.1M | 1.82% | 294,400 -32,768 | -10% | -$3.69M |
|
|
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.1M | 0.61% | 160,406 +88,649 | +124% | +$6.16M |
|
|
3
Alkermes
ALKS
$4.78B
| $10.5M | 0.57% | +131,671 | New | +$10.5M |
|
4
Tenax Therapeutics
TENX
$27.3M
| $8.84M | 0.49% | 2,693,537 +88,877 | +3% | +$292K |
|
|
TBRA
5
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $7.79M | 0.43% | 877,342 +702,399 | +402% | +$6.24M |
|
|
MBLY
6
DELISTED
Mobileye N.V.
MBLY
| $7.26M | 0.4% | 171,672 -64,147 | -27% | -$2.71M |
|
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -174,073 | Closed | -$18.3M |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.45M | 0.35% | 342,857 | – | – |
|
|
LUMO
9
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $6.23M | 0.34% | 171,266 +137,608 | +409% | +$5.01M |
|
|
VXZ
10
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $5.85M | 0.32% | 525,132 +74,632 | +17% | +$831K |
|
|
11
United Therapeutics
UTHR
$13.8B
| $5.45M | 0.3% | +34,779 | New | +$5.45M |
|
12
Arbutus Biopharma
ABUS
$711M
| $4.45M | 0.24% | 1,000,000 +274,993 | +38% | +$1.22M |
|
13
Inovio Pharmaceuticals
INO
$126M
| $4.16M | 0.23% | 619,185 -118,366 | -16% | -$795K |
|
14
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.06M | 0.22% | +113,838 | New | +$4.06M |
|
|
ALPN
15
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $3.9M | 0.21% | 503,595 +118,861 | +31% | +$920K |
|
|
ASXC
16
DELISTED
Asensus Surgical, Inc.
ASXC
| $3.77M | 0.21% | 1,521,505 -69,612 | -4% | -$173K |
|
17
Indaptus Therapeutics
INDP
$7.19M
| $3.59M | 0.2% | 670,449 +56,539 | +9% | +$303K |
|
18
Plus Therapeutics
PSTV
$45.3M
| $3.19M | 0.18% | 17,150,297 +14,208,417 | +483% | +$2.64M |
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.96M | 0.16% | 617,496 +248,855 | +68% | +$1.19M |
|
|
CEMP
20
DELISTED
Cempra, Inc.
CEMP
| $2.95M | 0.16% | 94,763 +21,568 | +29% | +$671K |
|
|
NWBO
21
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $2.94M | 0.16% | 917,942 +345,424 | +60% | +$1.11M |
|
|
BLUE
22
DELISTED
bluebird bio
BLUE
| $2.92M | 0.16% | +45,449 | New | +$2.92M |
|
|
ONCS
23
DELISTED
OncoSec Medical Incorporated
ONCS
| $2.9M | 0.16% | 1,224,359 +884,190 | +260% | +$2.1M |
|
24
Dynavax Technologies
DVAX
$1.19B
| $2.9M | 0.16% | 120,000 -14,954 | -11% | -$361K |
|
25
Standard BioTools
LAB
$481M
| $2.86M | 0.16% | 264,196 -364,064 | -58% | -$3.94M |
|